-
6 days ago | 
ddw-online.com | Diana Spencer
FUJIFILM Irvine Scientific, headquartered in Santa Ana, California is to rebrand as FUJIFILM Biosciences as part of a new structure and strategy for the group. FUJIFILM Corporation’s Life Sciences Group says the new names, collaborative strategic focus, and structural alignment reflects its commitment to life sciences.
-
6 days ago | 
ddw-online.com | Diana Spencer
Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. The webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in drug discovery and development.
-
6 days ago | 
ddw-online.com | Diana Spencer
On Tuesday 4 November DDW will be holding its Turning Science into Business Symposium at the Francis Crick Institute in London. Six in-depth topic presentations from industry experts will be followed by a panel discussion examining new processes and technology, with a focus on how they can create efficiencies and expedite drug discovery.
-
1 week ago | 
ddw-online.com | Diana Spencer
This free webinar at 3pm BST on 12 June, hosted by DDW and sponsored by Scale Biosciences, will see experts and thought-leaders from the cancer research sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects in the oncology field. Presenters include Roy Maute, CEO and co-founder of Pheast Therapeutics, and Rachel Grimley, Senior Vice President of Drug Discovery at Cancer Research UK.
-
1 week ago | 
ddw-online.com | Diana Spencer
Scientists have developed a method for analysing the structure of lipid nanoparticles that could be used to improve vaccine and drug delivery. A team led by scientists at the University of Nottingham’s School of Pharmacy demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen lipid nanoparticles (LNPs) to reveal the layers and orientation of the constituent molecules.
-
1 week ago | 
ddw-online.com | Diana Spencer
Organ-on-a-chip (OOC) company CN Bio has agreed a strategic partnership with SCINCO, a specialist scientific instrument company based in South Korea. The agreement is designed to amplify the CN Bio’s presence in major Asian and Pacific markets and broaden access to its predictive human organ models. CN Bio is establishing regional supply networks through specialist distribution partners to meet demand for its PhysioMimix OOC System and solutions.
-
1 week ago | 
ddw-online.com | Diana Spencer
As the field of gene therapy advances, the need for fast, accurate, and scalable characterisation of adeno-associated virus (AAV) products and the plasmids used to produce them has never been greater. Join Oxford Nanopore Technologies and Plasmidsaurus on 11 June at 5pm BST for an expert-led webinar, hosted by DDW, showcasing new and improved genomics solutions for gene therapy development and vector quality control.
-
1 week ago | 
ddw-online.com | Diana Spencer
Eli Lilly has entered into an agreement to develop and commercialise novel RNA-editing therapies using Rznomics’ proprietary trans-splicing ribozyme platform. Rznomics is a clinical-stage biopharmaceutical company based in South Korea focused on developing RNA-based gene therapies. The collaboration focuses on the discovery and development of RNA-editing therapeutics for sensorineural hearing loss.
-
1 week ago | 
ddw-online.com | Diana Spencer
University of Michigan (U-M) spinout company Courage Therapeutics has received a seed investment of up to $7.8 million from Arsenal Bridge Ventures. The investment will enable Courage Therapeutics to complete essential testing and development to advance its drug candidates to clinical trials.
-
1 week ago | 
ddw-online.com | Diana Spencer
Hosted by Drug Discovery World and sponsored by Emulate, this free webinar will explore where innovation is taking place within neuroscience drug discovery. The webinar will see experts and leaders from the neuroscience sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects targeting neuroscience. You will hear from Gene Mack, CEO of Gain Therapeutics, Farid Khan, CSO of Chief AI, and Gautam Mahajan, Principal Scientific Lead at Emulate.
